Last year, fDi Markets tracked 11 R&D projects into China, for $1.3bn, compared with 17projects totalling $327m into the US. The previous year, China received 24 R&D projectsat nearly $1.4bn, in a year when global greenfield expenditure on R&D projectscontinued a decline seen since 2011.
去年,fDi Markets追踪了中国吸引的11个研发项目,价值13亿美元,美国为17个项目,总价值3.27亿美元。2013年,中国吸引了近14亿美元、24个研发项目投资,当年,全球绿地研发投资支出延续自2011年以来的下滑势头。
The pharmaceuticals sector is leading R&D investment in China, accounting for $1.6bn lastyear. Business machines and equipment ($817m) and consumer electronics ($540m) were thesecond and third most active sectors, suggesting a healthy spread of research-intensiveactivity across key industries. US companies are the most active R&D investors in China,with 32 companies spending $1.6bn on 36 projects in 2014, according to fDi Markets.
制药行业是中国首要的研发投资领域,去年吸引了16亿美元投资。商业机器和设备(8.17亿美元)以及消费电子(5.4亿美元)分列第二和第三,这表明,研究密集型活动在各个关键行业之间呈现健康分布。在中国进行研发投资的外国公司中,美国公司最为活跃——根据fDi Markets的数据,去年,有32家美国公司在中国36个项目上支出16亿美元。
【中国获研发FDI规模超美国】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15